Breastfeeding patterns among parturients with diabetes: A secondary analysis of the MOMPOD randomized clinical trial
Stillmuster bei Gebärenden mit Diabetes: Sekundäranalyse der randomisierten MOMPOD-Studie
Pregnancy · 2025-01 · 1 (1)
DOI: 10.1002/pmf2.12040 ↗Auf einen Blick
In einer Sekundäranalyse der MOMPOD-Studie war Metformin in der Schwangerschaft nicht mit besseren Stillmustern verbunden. Weder der Stillbeginn noch das Stillen nach 30 Tagen unterschieden sich gegenüber Placebo.
Fragestellung
Besteht bei Schwangeren mit Typ-2- oder früher Diabetes ein Zusammenhang zwischen Metformin in der Schwangerschaft und Stillbeginn bzw. Stillfortsetzung?
Methode
Sekundäranalyse einer randomisierten kontrollierten Studie (MOMPOD); Metformin vs. Placebo zusätzlich zu Insulin; Befragung zu Stillabsicht und Stilloutcomes.
Ergebnisse
Von 794 randomisierten und behandelten Frauen erfüllten 378 die Einschlusskriterien. Stillen direkt postpartum: 91,1 % vs. 88,9 % (p = 0,53); nach 30 Tagen: 76,0 % vs. 66,7 % (p = 0,11).
Schlussfolgerung der Autor:innen
Die Autor:innen sehen keinen Zusammenhang zwischen Metformin in der Schwangerschaft und Stillmustern bei Typ-2- oder früher Diabetes. Metformin ante partum sollte nicht allein zur Verbesserung des Stillerfolgs empfohlen werden.
Kernaussagen
- Metformin zeigte keinen Vorteil für den Stillbeginn direkt postpartum.
- Auch nach 30 Tagen ergab sich kein Unterschied gegenüber Placebo.
- Keine Unterschiede bei exklusivem/partiellem Stillen oder Stillproblemen.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pregnancy, online erschienen am 28.01.2025. Verfasst von Minhazur Sarker und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Diego, San Diego, CA USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, National Institutes of Health.
Themen: Hebammenwesen und Geburtshilfe, Stillen, Diabetes mellitus
Abstract (Originalsprache)
Introduction
Insulin resistance is associated with decreased milk supply in lactating people. Metformin is hypothesized to increase breast milk production by decreasing insulin resistance, suggesting use may increase breastfeeding success. We aimed to determine the association between metformin use during pregnancy and breastfeeding initiation and continuation.
Methods
This was a secondary analysis of the MOMPOD randomized controlled trial of metformin versus placebo in addition to insulin therapy among pregnant people with type 2 diabetes and early diabetes. We included parturients who delivered a living neonate, received at least one dose of study drug or placebo, endorsed an intention to breastfeed, and completed a breastfeeding survey. Breastfeeding intentions and breastfeeding outcomes were collected utilizing a breastfeeding questionnaire at 24–30 weeks and 30 days postpartum, respectively. The primary outcome was breastfeeding at 30 days postpartum defined by exclusive or partial breastfeeding. Secondary outcomes included immediate breastfeeding defined as any breastfeeding during the postpartum hospital admission until at least postpartum day 3, onset of lactogenesis (days), breast and bra size, and breastfeeding challenges. Baseline characteristics and outcomes were compared using chi‐square, t ‐test, or Wilcoxon tests, as appropriate.
Results
Among the 794 women randomized and receiving either placebo or metformin in the primary trial, 378 (47.6%) met inclusion criteria with 194 (51.3%) in metformin and 184 (48.7%) in placebo groups. There were no significant differences in baseline characteristics. Immediate breastfeeding was comparable between groups (91.1% vs. 88.9%, p = 0.53) and there was no difference in onset of lactogenesis. Breastfeeding rates were lower among all parturients 30 days postpartum and there was no difference between metformin and placebo groups (76.0% vs. 66.7%, p = 0.11). Also, there were no differences in partial or exclusive breastfeeding, breast cup or bra size, or breastfeeding challenges.
Conclusion
Our data suggest no association between metformin use and breastfeeding patterns in those with type 2 or early diabetes in pregnancy. Antepartum metformin should not be recommended solely to improve breastfeeding success.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of California San Diego, San Diego, CA USA.
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC USA.
- University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL USA.
- University of Texas Health Houston McGovern Medical School, Houston, TX USA.
- Columbia University Irving Medical Center, New York, NY USA.
- University of South Carolina School of Medicine Greenville/Prisma Health-Upstate, Greenville, SC USA.
Förderung
- NIDDK NIH HHS
- NICHD NIH HHS
- National Institutes of Health
Zitieren
APA
Sarker, M., Jacobs, M. B., Boggess, K., Battarbee, A. N., Refuerzo, J., Zork, N., Eichelberger, K., Durnwald, C., Landon, M., Aagaard, K., Wallace, K., Scifres, C., Longo, S., Stuebe, A., & Ramos, G. A. (2025). Breastfeeding patterns among parturients with diabetes: A secondary analysis of the MOMPOD randomized clinical trial. Pregnancy, 1(1). https://doi.org/10.1002/pmf2.12040
Vancouver
Sarker M, Jacobs MB, Boggess K, Battarbee AN, Refuerzo J, Zork N, et al. Breastfeeding patterns among parturients with diabetes: A secondary analysis of the MOMPOD randomized clinical trial. Pregnancy. 2025;1(1). doi:10.1002/pmf2.12040
BibTeX
@article{Sarker2025,
author = {Sarker, Minhazur and Jacobs, Marni B and Boggess, Kim and Battarbee, Ashley N and Refuerzo, Jerrie and Zork, Noelia and Eichelberger, Kacey and Durnwald, Celeste and Landon, Mark and Aagaard, Kjersti and Wallace, Kedra and Scifres, Christina and Longo, Sherri and Stuebe, Alison and Ramos, Gladys A},
title = {Breastfeeding patterns among parturients with diabetes: A secondary analysis of the MOMPOD randomized clinical trial},
journal = {Pregnancy},
year = {2025},
volume = {1},
number = {1},
doi = {10.1002/pmf2.12040}
}
EUVIMED